Brief: Scopus Biopharma Retaining Counsel To Investigate Unusual Market Activity
01/10/2021 21:33
Oct 1 (Reuters) - Scopus Biopharma Inc SCPS.O :
* SCOPUS BIOPHARMA RETAINING COUNSEL TO INVESTIGATE UNUSUAL
MARKET
ACTIVITY
* SCOPUS BIOPHARMA - RETAINING BOIES SCHILLER FLEXNER LLP TO
CONDUCT MARKET MANIPULATION INVESTIGATION
* SCOPUS BIOPHARMA - BOIES SCHILLER FLEXNER TO REFER ALL
SECURITIES, OTHER VIOLATIONS IT UNCOVERS TO APPROPRIATE CRIMINAL
AND REGULATORY AUTHORITIES
Source text for Eikon: ID:nGNX34rfVR
Further company coverage: SCPS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scopus Biopharma
See all newsBrief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq
Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value
Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq
Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq
Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule